3,554 Shares in HealthEquity, Inc. (NASDAQ:HQY) Bought by Ethic Inc.

Ethic Inc. purchased a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 3,554 shares of the company's stock, valued at approximately $341,000.

A number of other hedge funds have also recently bought and sold shares of HQY. Pier Capital LLC bought a new position in shares of HealthEquity during the 4th quarter worth about $8,024,000. HighTower Advisors LLC grew its position in shares of HealthEquity by 4.8% during the 4th quarter. HighTower Advisors LLC now owns 95,075 shares of the company's stock worth $9,122,000 after buying an additional 4,370 shares during the period. Wells Fargo & Company MN raised its stake in shares of HealthEquity by 4.7% during the fourth quarter. Wells Fargo & Company MN now owns 124,940 shares of the company's stock worth $11,988,000 after buying an additional 5,594 shares during the last quarter. Geneva Capital Management LLC lifted its holdings in HealthEquity by 24.6% in the fourth quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company's stock valued at $100,642,000 after buying an additional 206,894 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its stake in HealthEquity by 2.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,086,811 shares of the company's stock valued at $104,280,000 after acquiring an additional 25,004 shares during the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Trading Up 3.7%

Shares of HealthEquity stock traded up $3.58 during midday trading on Tuesday, reaching $101.18. The company had a trading volume of 1,142,791 shares, compared to its average volume of 796,198. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The firm has a market cap of $8.75 billion, a PE ratio of 92.83, a P/E/G ratio of 1.60 and a beta of 0.45. The stock has a fifty day moving average price of $87.92 and a 200 day moving average price of $97.20. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $115.59.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. Barrington Research reissued an "outperform" rating and issued a $112.00 price target on shares of HealthEquity in a report on Friday, April 11th. Raymond James upgraded shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and reduced their price objective for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. The Goldman Sachs Group dropped their price objective on HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a research note on Thursday, March 27th. KeyCorp decreased their price objective on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a report on Wednesday, April 16th. Finally, Wells Fargo & Company lifted their target price on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $111.75.

Insider Activity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total transaction of $446,487.50. Following the sale, the director now owns 84,969 shares in the company, valued at $6,597,842.85. This represents a 6.34% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Michael Henry Fiore sold 8,881 shares of the firm's stock in a transaction dated Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the transaction, the executive vice president now owns 56,655 shares of the company's stock, valued at approximately $4,433,820.30. This represents a 13.55% decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by company insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.